Postoperative transcatheter arterial chemoembolization should be recommended in the hepatocellular carcinoma treatment guidelines of the American Association for the Study of Liver Diseases
Zhidong Wang, Zongfang Li, Yuanyuan Ji – 26 May 2011
Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation
Valeria Mas, Daniel Maluf, Kellie J. Archer, Amiee Potter, Jihee Suh, Ricardo Gehrau, Valeria Descalzi, Federico Villamil – 26 May 2011 – Allograft gene expression analysis may provide insights into the mechanisms involved in liver damage during hepatitis C virus recurrence (HCVrec) after orthotopic liver transplantation (OLT) and allow the identification of patients who have a higher risk of developing severe disease. Forty‐three OLT recipients with hepatitis C virus (HCV) were evaluated.
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis
Ruben Hernaez, Mariana Lazo, Susanne Bonekamp, Ihab Kamel, Frederick L. Brancati, Eliseo Guallar, Jeanne M. Clark – 26 May 2011 – Ultrasonography is a widely accessible imaging technique for the detection of fatty liver, but the reported accuracy and reliability have been inconsistent across studies. We aimed to perform a systematic review and meta‐analysis of the diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver. We used MEDLINE and Embase from October 1967 to March 2010.
Reviving pegylated interferon as a therapeutic agent for hepatitis D: No more room for nucleos(t)ides?
Holger H. Lutz, Christian Trautwein – 25 May 2011
Reply
Hitendra Garg, Shiv Kumar Sarin, Manoj Kumar, Vishal Garg, Barjesh Chander Sharma, Ashish Kumar – 23 May 2011
Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties
Francesca Rossi, Giulia Bellini, Bruno Nobili, Sabatino Maione, Laura Perrone, Emanuele Miraglia del Giudice – 23 May 2011
Stem cells or macrophages: Which contribute to bone marrow cell therapy for liver cirrhosis?
Tao Liu, Yingjie Wang, Chenting Wen, Shichang Zhang, Chunmei Zhang – 23 May 2011
MicroRNAs‐372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B
Hongyan Guo, Haiying Liu, Keith Mitchelson, Huiying Rao, Mingyong Luo, Lan Xie, Yimin Sun, Liang Zhang, Ying Lu, Ruyu Liu, Aihui Ren, Shuai Liu, Shaozhen Zhou, Jiye Zhu, Yuxiang Zhou, Ailong Huang, Lai Wei, Yong Guo, Jing Cheng – 23 May 2011 – MicroRNAs (miRNAs) play important roles in the posttranscriptional regulation of gene expression. Recent evidence has indicated the pathological relevance of miRNA dysregulation in hepatitis virus infection; however, the roles of microRNAs in the regulation of hepatitis B virus (HBV) expression are still largely unknown.
Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma
Amr Amin, Alaaeldin A. Hamza, Khuloud Bajbouj, S. Salman Ashraf, Sayel Daoud – 23 May 2011 – Saffron has been proposed as a promising candidate for cancer chemoprevention. The purpose of this investigation was to investigate the chemopreventive action and the possible mechanisms of saffron against diethylnitrosamine (DEN)‐induced liver cancer in rats. Administration of saffron at doses of 75, 150, and 300 mg/kg/day was started 2 weeks prior to the DEN injection and was continued for 22 weeks.